JP2018086274A5 - - Google Patents

Download PDF

Info

Publication number
JP2018086274A5
JP2018086274A5 JP2017254812A JP2017254812A JP2018086274A5 JP 2018086274 A5 JP2018086274 A5 JP 2018086274A5 JP 2017254812 A JP2017254812 A JP 2017254812A JP 2017254812 A JP2017254812 A JP 2017254812A JP 2018086274 A5 JP2018086274 A5 JP 2018086274A5
Authority
JP
Japan
Prior art keywords
rpe
cell preparation
cells
rpe cell
macular degeneration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2017254812A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018086274A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018086274A publication Critical patent/JP2018086274A/ja
Publication of JP2018086274A5 publication Critical patent/JP2018086274A5/ja
Ceased legal-status Critical Current

Links

JP2017254812A 2004-01-23 2017-12-28 網膜変性疾患治療のための改良された様式 Ceased JP2018086274A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53896404P 2004-01-23 2004-01-23
US60/538,964 2004-01-23

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016152133A Division JP2016195862A (ja) 2004-01-23 2016-08-02 網膜変性疾患治療のための改良された様式

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019170249A Division JP2019217356A (ja) 2004-01-23 2019-09-19 網膜変性疾患治療のための改良された様式

Publications (2)

Publication Number Publication Date
JP2018086274A JP2018086274A (ja) 2018-06-07
JP2018086274A5 true JP2018086274A5 (cg-RX-API-DMAC7.html) 2018-11-29

Family

ID=34807248

Family Applications (10)

Application Number Title Priority Date Filing Date
JP2006551392A Pending JP2007522131A (ja) 2004-01-23 2005-01-24 網膜変性疾患治療のための改良された様式
JP2012040491A Pending JP2012148085A (ja) 2004-01-23 2012-02-27 網膜変性疾患治療のための改良された様式
JP2014016135A Ceased JP2014079650A (ja) 2004-01-23 2014-01-30 網膜変性疾患治療のための改良された様式
JP2015025500A Ceased JP2015096556A (ja) 2004-01-23 2015-02-12 網膜変性疾患治療のための改良された様式
JP2016152133A Withdrawn JP2016195862A (ja) 2004-01-23 2016-08-02 網膜変性疾患治療のための改良された様式
JP2017254812A Ceased JP2018086274A (ja) 2004-01-23 2017-12-28 網膜変性疾患治療のための改良された様式
JP2019170249A Pending JP2019217356A (ja) 2004-01-23 2019-09-19 網膜変性疾患治療のための改良された様式
JP2020105536A Ceased JP2020146575A (ja) 2004-01-23 2020-06-18 網膜変性疾患治療のための改良された様式
JP2022124147A Pending JP2022153630A (ja) 2004-01-23 2022-08-03 網膜変性疾患治療のための改良された様式
JP2024007584A Pending JP2024038460A (ja) 2004-01-23 2024-01-22 網膜変性疾患治療のための改良された様式

Family Applications Before (5)

Application Number Title Priority Date Filing Date
JP2006551392A Pending JP2007522131A (ja) 2004-01-23 2005-01-24 網膜変性疾患治療のための改良された様式
JP2012040491A Pending JP2012148085A (ja) 2004-01-23 2012-02-27 網膜変性疾患治療のための改良された様式
JP2014016135A Ceased JP2014079650A (ja) 2004-01-23 2014-01-30 網膜変性疾患治療のための改良された様式
JP2015025500A Ceased JP2015096556A (ja) 2004-01-23 2015-02-12 網膜変性疾患治療のための改良された様式
JP2016152133A Withdrawn JP2016195862A (ja) 2004-01-23 2016-08-02 網膜変性疾患治療のための改良された様式

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2019170249A Pending JP2019217356A (ja) 2004-01-23 2019-09-19 網膜変性疾患治療のための改良された様式
JP2020105536A Ceased JP2020146575A (ja) 2004-01-23 2020-06-18 網膜変性疾患治療のための改良された様式
JP2022124147A Pending JP2022153630A (ja) 2004-01-23 2022-08-03 網膜変性疾患治療のための改良された様式
JP2024007584A Pending JP2024038460A (ja) 2004-01-23 2024-01-22 網膜変性疾患治療のための改良された様式

Country Status (15)

Country Link
US (6) US7736896B2 (cg-RX-API-DMAC7.html)
EP (8) EP4248752A3 (cg-RX-API-DMAC7.html)
JP (10) JP2007522131A (cg-RX-API-DMAC7.html)
KR (3) KR101258292B1 (cg-RX-API-DMAC7.html)
CN (3) CN104434979A (cg-RX-API-DMAC7.html)
AU (6) AU2005207042B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0507074A (cg-RX-API-DMAC7.html)
CA (2) CA2937099A1 (cg-RX-API-DMAC7.html)
ES (1) ES2721174T3 (cg-RX-API-DMAC7.html)
HK (2) HK1216068A1 (cg-RX-API-DMAC7.html)
IL (3) IL177015B (cg-RX-API-DMAC7.html)
MX (4) MX375061B (cg-RX-API-DMAC7.html)
NZ (1) NZ548929A (cg-RX-API-DMAC7.html)
SG (4) SG155236A1 (cg-RX-API-DMAC7.html)
WO (1) WO2005070011A2 (cg-RX-API-DMAC7.html)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8043614B2 (en) * 2004-03-09 2011-10-25 Ahlfors Jan-Eric W Autogenic living scaffolds and living tissue matrices: methods and uses thereof
EP4248752A3 (en) 2004-01-23 2024-01-03 President And Fellows Of Harvard College Improved modalities for the treatment of degenerative diseases of the retina
US7794704B2 (en) 2004-01-23 2010-09-14 Advanced Cell Technology, Inc. Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
EP1812554A4 (en) 2004-11-04 2008-10-08 Advanced Cell Tech Inc DERIVATION OF EMBRYONAL STEM CELLS
US7893315B2 (en) 2004-11-04 2011-02-22 Advanced Cell Technology, Inc. Derivation of embryonic stem cells and embryo-derived cells
CN1966080B (zh) * 2005-11-17 2011-06-08 李凌松 一种治疗老年痴呆症、帕金森病的神经干细胞注射液
US7541186B2 (en) * 2006-02-22 2009-06-02 University Of Washington Method of generating human retinal progenitors from embryonic stem cells
KR20150142061A (ko) 2006-05-03 2015-12-21 오카타 세라퓨틱스, 인크. 배아 줄기 세포 및 배-유도 세포의 유도
US9133435B2 (en) * 2007-01-18 2015-09-15 Riken Method for induction/differentiation into photoreceptor cell
CA2679109C (en) 2007-02-23 2016-07-19 Advanced Cell Technology, Inc. Derivation of embryonic stem cells
WO2008129554A1 (en) * 2007-04-18 2008-10-30 Hadasit Medical Research Services & Development Limited Stem cell-derived retinal pigment epithelial cells
US8574567B2 (en) 2007-05-03 2013-11-05 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
WO2008137115A1 (en) 2007-05-03 2008-11-13 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
US20090028831A1 (en) * 2007-07-23 2009-01-29 University Of Kentucky Research Foundation Stem cell regulator, compositions and methods of use
KR101849329B1 (ko) * 2007-10-12 2018-04-16 아스텔라스 인스티튜트 포 리제너러티브 메디슨 Rpe 세포의 개선된 생산 방법 및 rpe 세포의 조성물
AU2015201435B2 (en) * 2007-10-12 2017-02-02 Astellas Institute For Regenerative Medicine Improved methods of producing RPE cells and compositions of RPE cells
WO2009132156A1 (en) * 2008-04-22 2009-10-29 Regenerative Research Foundation Retinal pigment epithelial stem cells
WO2011028524A1 (en) 2009-08-24 2011-03-10 Wisconsin Alumni Research Foundation Substantially pure human retinal progenitor, forebrain progenitor, and retinal pigment epithelium cell cultures and methods of making the same
US10485829B2 (en) 2009-11-17 2019-11-26 Astellas Institute For Regenerative Medicine Methods of producing human RPE cells and pharmaceutical preparations of human RPE cells
EP3549617B1 (en) 2010-07-12 2023-09-13 University of Southern California Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
HUE054517T2 (hu) 2010-07-23 2021-09-28 Astellas Inst For Regenerative Medicine Eljárások sejtek ritka alpopulációinak detektálására és nagymértékben tisztított sejtkészítmények
JP2012231786A (ja) * 2011-04-18 2012-11-29 Kyushu Univ 標的遺伝子の発現変化による食品機能成分及び医薬品感受性評価方法
US8877489B2 (en) 2011-12-05 2014-11-04 California Institute Of Technology Ultrathin parylene-C semipermeable membranes for biomedical applications
US10478206B2 (en) 2011-04-29 2019-11-19 University Of Southern California Instruments and methods for the implantation of cell-seeded substrates
AU2012256014B2 (en) 2011-05-13 2016-10-27 Elixirgen, Llc Use of Zscan4 and Zscan4-dependent genes for direct reprogramming of somatic cells
CN111265551A (zh) * 2011-05-18 2020-06-12 加利福尼亚大学董事会 用于治疗视网膜疾病的组合物及方法
WO2013015835A1 (en) 2011-07-22 2013-01-31 Seven Networks, Inc. Mobile application traffic optimization
CN103007355B (zh) * 2011-09-20 2014-08-13 同济大学 一种水凝胶-纳米纤维膜及其制备方法和用途
IL320536A (en) 2011-11-14 2025-06-01 Astellas Inst For Regenerative Medicine Pharmaceutical preparations of human RPE cells and their use
US8961956B2 (en) 2011-11-30 2015-02-24 Ocata Therapeutics, Inc. Mesenchymal stromal cells and uses related thereto
CA2857545A1 (en) 2011-11-30 2013-06-06 Advanced Cell Technology, Inc. Mesenchymal stromal cells and uses related thereto
US9248013B2 (en) 2011-12-05 2016-02-02 California Institute Of Technology 3-Dimensional parylene scaffold cage
CN104136601A (zh) * 2012-02-17 2014-11-05 斯格本斯眼科研究所 人视网膜祖细胞的表型谱
US10519422B2 (en) 2012-02-29 2019-12-31 Riken Method of producing human retinal pigment epithelial cells
WO2014011407A2 (en) 2012-07-12 2014-01-16 Imstem Biotechnology, Inc. Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
US11033586B2 (en) * 2012-08-24 2021-06-15 Riken Method for producing retinal pigment epithelial cell sheet
CN118995611A (zh) 2013-03-15 2024-11-22 安斯泰来再生医药协会 由多能干细胞产生的光感受器和光感受器祖细胞
US11241460B2 (en) 2013-03-15 2022-02-08 Astellas Institute For Regenerative Medicine Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
EP2980207B1 (en) * 2013-03-25 2018-12-05 Foundation for Biomedical Research and Innovation at Kobe Cell sorting method
EP2796545A1 (en) * 2013-04-26 2014-10-29 Université Pierre et Marie Curie (Paris 6) Methods for obtaining retinal progenitors, retinal pigmented epithelial cells and neural retinal cells
ES2763433T3 (es) 2013-11-27 2020-05-28 Kyoto Prefectural Public Univ Corp Aplicación de laminina a cultivos de células endoteliales de la córnea
WO2015087231A1 (en) 2013-12-11 2015-06-18 Pfizer Limited Method for producing retinal pigment epithelial cells
US11633477B2 (en) 2014-10-31 2023-04-25 Kyoto Prefectural Public University Corporation Treatment of cornea using laminin
EP3213761B1 (en) * 2014-10-31 2021-05-19 Kyoto Prefectural Public University Corporation Novel treatment of retina using laminin
SG10201907918VA (en) 2015-03-23 2019-10-30 Astellas Inst For Regenerative Medicine Improved assays for potency of human retinal pigment epithelium (rpe) cells and photoreceptor progenitors
KR102651291B1 (ko) 2015-08-18 2024-03-26 아스텔라스 인스티튜트 포 리제너러티브 메디슨 임상 제제
CN108350421A (zh) 2015-09-08 2018-07-31 大日本住友制药株式会社 用于制备视网膜色素上皮细胞的方法
EP3347457B1 (en) 2015-09-08 2021-10-27 FUJIFILM Cellular Dynamics, Inc. Macs-based purification of stem cell-derived retinal pigment epithelium
AU2016321170B2 (en) 2015-09-08 2022-09-01 Fujifilm Cellular Dynamics Method for reproducible differentiation of clinical-grade retinal pigment epithelium cells
US10947502B2 (en) 2015-10-20 2021-03-16 FUJIFILM Cellular Dynamics, Inc. Methods for directed differentiation of pluripotent stem cells to immune cells
CN106609263B (zh) * 2015-10-22 2020-04-07 同济大学 高效诱导多能干细胞向视网膜色素上皮细胞分化的方法
CN106609255B (zh) * 2015-10-22 2019-11-05 同济大学 含pj34和视网膜色素上皮细胞的细胞悬液及其应用
CN106609257B (zh) * 2015-10-22 2020-04-10 同济大学 高效分离体外诱导的rpe细胞和rpc的方法
CN106609256B (zh) * 2015-10-22 2020-04-07 同济大学 体外诱导人胚胎干细胞分化为视网膜色素上皮细胞的方法
CN106282096A (zh) * 2016-10-19 2017-01-04 江苏艾尔康生物医药科技有限公司 一种人类视网膜色素上皮细胞层的分离培养方法
EP3594322A4 (en) 2017-03-08 2021-01-27 Sumitomo Dainippon Pharma Co., Ltd. RETINAL PIGMENTARY EPITHELIAL CELL PRODUCTION PROCESS
JP2020511539A (ja) * 2017-03-16 2020-04-16 リネージ セル セラピューティクス インコーポレイテッド 網膜疾患治療法の治療効果を測定する方法
EP4083063A3 (en) 2017-04-18 2023-01-04 FUJIFILM Cellular Dynamics, Inc. Antigen-specific immune effector cells
CN111094548A (zh) * 2017-09-14 2020-05-01 国立研究开发法人理化学研究所 基于背侧化信号转导物质或腹侧化信号转导物质的增加视锥细胞或视杆细胞的方法
CA3082080A1 (en) 2017-11-15 2019-05-23 Friedrich Miescher Institute For Biomedical Research Primate retinal pigment epithelium cell-specific promoter
CN108029638B (zh) * 2017-12-04 2020-04-21 四川省人民医院 一种视网膜色素变性疾病动物模型的构建方法及应用
US11946069B2 (en) 2018-03-12 2024-04-02 RxCell, Inc. Method for generating multiple cellular products from single pluripotent cell source
KR20220004097A (ko) 2019-04-26 2022-01-11 고쿠리쓰 겐큐 가이하쓰 호징 리가가쿠 겐큐소 신경 망막과 망막 색소 상피 세포와 하이드로겔을 포함하는 복합체 및 그의 제조 방법
KR20220106965A (ko) 2019-10-30 2022-08-01 아스텔라스 인스티튜트 포 리제너러티브 메디슨 망막 색소 상피 세포의 생성 방법
RU2730937C1 (ru) * 2019-11-01 2020-08-26 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр глазных болезней имени Гельмгольца" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ГБ им. Гельмгольца" Миндрава России) Способ трансплантации клеток ретинального пигментного эпителия (РПЭ), дифференцированных из индуцированных плюрипотентных стволовых клеток человека, при атрофии ретинального пигментного эпителия
WO2022191216A1 (ja) 2021-03-09 2022-09-15 国立研究開発法人理化学研究所 低免疫原性網膜色素上皮細胞の製造方法
CN118302517A (zh) 2021-11-19 2024-07-05 国立研究开发法人理化学研究所 片状视网膜组织的制造方法
CN118871141A (zh) 2022-03-16 2024-10-29 住友制药株式会社 移植用介质
CN119384700A (zh) 2022-04-15 2025-01-28 艾斯本神经科学公司 细胞分化状态的分类方法和分化细胞的相关组合物
JPWO2024172043A1 (cg-RX-API-DMAC7.html) 2023-02-14 2024-08-22

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE196923T1 (de) 1993-04-30 2000-10-15 Photogenesis Inc Transplantation des retinalen pigmentepithels
US6878544B2 (en) 1996-04-19 2005-04-12 Neurotech Sa Retinal cell lines with extended life-span and their applications
US20040086494A1 (en) 1996-10-07 2004-05-06 John Constance Mary Immune privileged cells for delivery of proteins and peptides
AU5734998A (en) 1997-01-10 1998-08-03 Life Technologies, Inc. Embryonic stem cell serum replacement
US6331406B1 (en) * 1997-03-31 2001-12-18 The John Hopkins University School Of Medicine Human enbryonic germ cell and methods of use
CA2317115A1 (en) 1998-01-02 1999-07-15 Titan Pharmaceuticals, Inc. Use of pigmented retinal epithelial cells for creation of an immune privilege site
EP1066368A4 (en) 1998-03-02 2002-08-21 Compucyte Corp SELECTIVE CELL ANALYSIS
US6667176B1 (en) 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
US6331313B1 (en) 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
AU782846B2 (en) 1999-10-28 2005-09-01 University Of Massachusetts Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
JP3454206B2 (ja) * 1999-11-10 2003-10-06 三菱電機株式会社 雑音抑圧装置及び雑音抑圧方法
JP2003533976A (ja) 2000-01-07 2003-11-18 オレゴン ヘルス アンド サイエンス ユニバーシティ 胚分割による霊長類子孫のクローン性増殖
US6602711B1 (en) * 2000-02-21 2003-08-05 Wisconsin Alumni Research Foundation Method of making embryoid bodies from primate embryonic stem cells
US20030084471A1 (en) * 2000-03-16 2003-05-01 David Beach Methods and compositions for RNA interference
US6458589B1 (en) 2000-04-27 2002-10-01 Geron Corporation Hepatocyte lineage cells derived from pluripotent stem cells
CN1311081C (zh) 2000-08-19 2007-04-18 爱克斯澳迪亚有限公司 干细胞分化
US6576464B2 (en) 2000-11-27 2003-06-10 Geron Corporation Methods for providing differentiated stem cells
ES2250504T3 (es) 2000-11-29 2006-04-16 Allergan Inc. Prevencion del rechazo de injerto en el ojo.
DE10108412B4 (de) * 2001-02-21 2006-03-09 Cevec Pharmaceuticals Gmbh Pigmentepithelzelle des Auges, ihre Herstellung und Verwendung in der Therapie einer Augen- oder Nervenerkrankung
WO2002092756A2 (en) 2001-05-15 2002-11-21 Rappaport Family Institute For Research In The Medical Sciences Insulin producing cells derived from human embryonic stem cells
US7425448B2 (en) 2001-07-12 2008-09-16 Geron Corporation Cardiomyocyte precursors from human embryonic stem cells
CA2468292A1 (en) * 2001-11-26 2003-06-05 Advanced Cell Technology, Inc. Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
WO2003049773A1 (en) 2001-12-11 2003-06-19 Fibrogen, Inc. Methods for inhibiting ocular processes
EP1495120B1 (en) 2002-04-18 2012-10-10 Acuity Pharmaceuticals, Inc Means and methods for the specific modulation of target genes in the eye
US7422736B2 (en) * 2002-07-26 2008-09-09 Food Industry Research And Development Institute Somatic pluripotent cells
US7824671B2 (en) 2002-10-04 2010-11-02 Tissuetech, Inc. Retinal pigment epithelial cell cultures on amniotic membrane and transplantation
JP4348706B2 (ja) * 2002-10-08 2009-10-21 日本電気株式会社 アレイ装置および携帯端末
US20040133095A1 (en) 2002-11-14 2004-07-08 Dunki-Jacobs Robert J. Methods and devices for detecting abnormal tissue cells
US20050032126A1 (en) 2003-03-03 2005-02-10 Coombs James H. Methods and apparatus for use in detection and quantitation of various cell types and use of optical bio-disc for performing same
EP4248752A3 (en) 2004-01-23 2024-01-03 President And Fellows Of Harvard College Improved modalities for the treatment of degenerative diseases of the retina
US7794704B2 (en) 2004-01-23 2010-09-14 Advanced Cell Technology, Inc. Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
EP1812554A4 (en) 2004-11-04 2008-10-08 Advanced Cell Tech Inc DERIVATION OF EMBRYONAL STEM CELLS
EP2048227B1 (en) 2005-02-11 2015-08-19 Agency For Science, Technology And Research Methods for proliferating stem cells
KR100832592B1 (ko) 2006-08-17 2008-05-27 박현숙 폴리머 막을 이용한 줄기세포와 피더세포의 공배양방법
WO2008129554A1 (en) 2007-04-18 2008-10-30 Hadasit Medical Research Services & Development Limited Stem cell-derived retinal pigment epithelial cells
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
KR101849329B1 (ko) 2007-10-12 2018-04-16 아스텔라스 인스티튜트 포 리제너러티브 메디슨 Rpe 세포의 개선된 생산 방법 및 rpe 세포의 조성물
HU0700675D0 (en) 2007-10-15 2007-12-28 Mta Tamogatott Kutatohelyek Ir Method for monitoring stem cell differentiation
US20090233324A1 (en) 2008-03-11 2009-09-17 Kopf-Sill Anne R Methods for Diagnosing Cancer Using Samples Collected From A Central Vein Location or an Arterial Location
US8652123B2 (en) 2008-09-02 2014-02-18 Geoffrey C. GURTNER Methods and devices for improving the appearance of tissue
US10485829B2 (en) 2009-11-17 2019-11-26 Astellas Institute For Regenerative Medicine Methods of producing human RPE cells and pharmaceutical preparations of human RPE cells
HUE054517T2 (hu) 2010-07-23 2021-09-28 Astellas Inst For Regenerative Medicine Eljárások sejtek ritka alpopulációinak detektálására és nagymértékben tisztított sejtkészítmények
JP6200883B2 (ja) 2011-04-29 2017-09-20 ユニヴァーシティー オブ サザン カリフォルニア ポリマー基質上の幹細胞由来網膜色素上皮細胞の低温保存方法
IL320536A (en) 2011-11-14 2025-06-01 Astellas Inst For Regenerative Medicine Pharmaceutical preparations of human RPE cells and their use
US9850463B2 (en) 2012-02-01 2017-12-26 The Regents Of The University Of California Methods of culturing retinal pigmented epithelium cells, including xeno-free production, RPE enrichment, and cryopreservation
US9458428B2 (en) 2012-06-05 2016-10-04 The Regents Of The University Of California Methods and compositions for the rapid production of retinal pigmented epithelial cells from pluripotent cells

Similar Documents

Publication Publication Date Title
JP2018086274A5 (cg-RX-API-DMAC7.html)
JP2015096556A5 (cg-RX-API-DMAC7.html)
JP2022153630A5 (cg-RX-API-DMAC7.html)
Chichagova et al. Cellular regeneration strategies for macular degeneration: past, present and future
JP2016510727A5 (cg-RX-API-DMAC7.html)
Seiler et al. Cell replacement and visual restoration by retinal sheet transplants
Carr et al. Development of human embryonic stem cell therapies for age-related macular degeneration
JP2014239904A5 (cg-RX-API-DMAC7.html)
JP2017532954A5 (cg-RX-API-DMAC7.html)
JP2018522593A5 (cg-RX-API-DMAC7.html)
JP2014000094A5 (ja) 臍帯由来細胞を用いた局部的または散在的脳外傷の改善
WO2016162747A3 (en) Methods and compositions for producing stem cell derived dopaminergic cells for use in treatment of neurodegenerative diseases
JP2017035113A5 (cg-RX-API-DMAC7.html)
IL256587A (en) Methods for the formation of epithelial pigment cells of the retina sorted from pluripotent stem cells
FI2780022T4 (fi) Pharmaceutical preparations of human rpe cells and uses thereof
EP4495133A3 (en) Methods of isolating t cells having antigenic specificity for a p53 cancer-specific mutation
JP2015521054A5 (cg-RX-API-DMAC7.html)
Li et al. Human induced pluripotent stem cells in Parkinson's disease: A novel cell source of cell therapy and disease modeling
JP2016515382A5 (cg-RX-API-DMAC7.html)
PH12014502508A1 (en) hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS
EP3492597A3 (en) Capsid-modified, raav3 vector compositions and methods of use in gene therapy of human liver cancer
AR087471A1 (es) Metodos de tratamiento de enfermedades degenerativas de la retina
JP2018502576A5 (cg-RX-API-DMAC7.html)
JP2016501013A5 (cg-RX-API-DMAC7.html)
EP4471130A3 (en) New immunoregulatory cells and methods for their production